News & Articles

Abbott will rapidly develop tests that can be used to help identify, isolate, and contain outbreaks when potential new virus threats are identified

With a footprint of 65,000 square meters, the new site has been designed from the ground up to accommodate demand, increasing capacity 10-fold

The findings come from the largest study to date to look at inflammatory markers in COVID-19

New line of bioreactors is designed to ensure seamless scalability from early process development to commercial manufacturing

The coveted ‘Eco-Nutrition’ label from My Green Lab represents the standard for lab sustainability

The statement includes a letter to manufacturers, guidance on identifying contaminants in food and next steps the agency will take

With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers

The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails

Avacta’s AffiDX SARS-CoV-2 lateral flow test detects both B117 ‘Kent’ and D614G variants of the virus

New service supports UK government test-to-release scheme for day 2 testing

For the first time Astronomy and Pathology (AstroPath™) come together to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence